-
EP3762493
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3762493
| EP3762493 - SYSTEMS AND METHODS FOR ASSESSING COLORECTAL CANCER MOLECULAR SUBTYPE AND RISK OF RECURRENCE AND FOR DETERMINING AND ADMINISTERING TREATMENT PROTOCOLS BASED THEREON [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 11.12.2020 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 14.09.2019 | Most recent event Tooltip | 08.05.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states University of Notre Dame du Lac 1400 East Angela Boulevard. South Bend, IN 46617 / US | [2021/02] | Inventor(s) | 01 /
BUECHLER, Steven 51210 Lexingham Drive Granger, Indiana 46530 / US | [2021/02] | Representative(s) | Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB | [2021/02] | Application number, filing date | 19764240.8 | 07.03.2019 | [2021/02] | WO2019US21234 | Priority number, date | US201862640157P | 08.03.2018 Original published format: US 201862640157 P | [2021/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019173644 | Date: | 12.09.2019 | Language: | EN | [2019/37] | Type: | A1 Application with search report | No.: | EP3762493 | Date: | 13.01.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.09.2019 takes the place of the publication of the European patent application. | [2021/02] | Search report(s) | International search report - published on: | US | 12.09.2019 | (Supplementary) European search report - dispatched on: | EP | 22.10.2021 | Classification | IPC: | C12N15/10, C12Q1/68, C40B40/06 | [2021/02] | CPC: |
C12Q1/6886 (EP,US);
G16B20/00 (EP);
G16B25/10 (US);
G16B30/00 (US);
G16B40/00 (US);
G16H10/40 (US);
G16H20/40 (US);
G16H50/20 (US);
G16H50/30 (EP);
G16H70/60 (US);
C12Q2600/106 (EP);
C12Q2600/112 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/154 (EP);
C12Q2600/156 (EP,US);
C12Q2600/158 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/02] | Title | German: | SYSTEME UND VERFAHREN ZUR BEURTEILUNG DES MOLEKULAREN SUBTYPS UND DES RÜCKFALLRISIKOS VON DARMKREBS UND ZUR BESTIMMUNG UND VERABREICHUNG DARAUF BASIERENDER BEHANDLUNGSPROTOKOLLE | [2021/02] | English: | SYSTEMS AND METHODS FOR ASSESSING COLORECTAL CANCER MOLECULAR SUBTYPE AND RISK OF RECURRENCE AND FOR DETERMINING AND ADMINISTERING TREATMENT PROTOCOLS BASED THEREON | [2021/02] | French: | SYSTÈMES ET PROCÉDÉS D'ÉVALUATION D'UN SOUS-TYPE MOLÉCULAIRE DE CANCER COLORECTAL ET RISQUE DE RÉCURRENCE ET DÉTERMINATION ET ADMINISTRATION DE PROTOCOLES DE TRAITEMENT BASÉS SUR CES DERNIERS | [2021/02] | Entry into regional phase | 07.10.2020 | National basic fee paid | 07.10.2020 | Search fee paid | 07.10.2020 | Designation fee(s) paid | 07.10.2020 | Examination fee paid | Examination procedure | 07.10.2020 | Examination requested [2021/02] | 09.05.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 12.03.2021 | Renewal fee patent year 03 | 14.01.2022 | Renewal fee patent year 04 | 21.03.2023 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.03.2024 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2011063274 (GENOMIC HEALTH INC [US], et al) [Y] 1-15 * claims 1-18 * * table 17 * * paragraph [0092] - paragraph [0133] *; | [A]WO2013052480 (UNIV TEXAS [US]) [A] 1-15 * claims 1-17 ** paragraphs [0003] - [0006] *; | [E]WO2019173647 (UNIV NOTRE DAME DU LAC [US]) [E] 1-15 * claims 1-19 * * tables 3a-3d *; | [T] - BUECHLER STEVEN A. ET AL, "ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing", SCIENTIFIC REPORTS, vol. 10, no. 1, doi:10.1038/s41598-020-69083-y, (20200721), URL: http://www.nature.com/articles/s41598-020-69083-y, XP055788551 [T] * the whole document * DOI: http://dx.doi.org/10.1038/s41598-020-69083-y | [XY] - JUSTIN GUINNEY ET AL, "The consensus molecular subtypes of colorectal cancer", NATURE MEDICINE, New York, (20151012), vol. 21, no. 11, doi:10.1038/nm.3967, ISSN 1078-8956, pages 1350 - 1356, XP055360839 [X] 11-15 * the whole document * [Y] 1-10 DOI: http://dx.doi.org/10.1038/nm.3967 | [XY] - ANITA SVEEN ET AL, "Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies", CLINICAL CANCER RESEARCH, US, (20171214), vol. 24, no. 4, doi:10.1158/1078-0432.CCR-17-1234, ISSN 1078-0432, pages 794 - 806, XP055465813 [X] 1,11-15 * the whole document * [Y] 2-10 DOI: http://dx.doi.org/10.1158/1078-0432.CCR-17-1234 | [XY] - Sveen Anita ET AL, "Supplementary Table S2. Overview and CMS groups of CRC cell lines a) Cell lines used for genomic analyses (various sources) Cell lines derived from unique patients Cell line (unique) Alternative names Primary tissue Metastasis", (20180215), URL: https://clincancerres.aacrjournals.org/highwire/filestream/159347/field_highwire_adjunct_files/1/182615_3_supp_4417047_p04pbf.xlsx, (20211014), XP055851345 [X] 1,11-15 * the whole document * * tables S7-S8 * [Y] 2-10 | [XY] - PETER W. EIDE ET AL, "CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models", SCIENTIFIC REPORTS, (20171130), vol. 7, no. 1, doi:10.1038/s41598-017-16747-x, XP055465931 [X] 11-15 * the whole document * [Y] 1-15 DOI: http://dx.doi.org/10.1038/s41598-017-16747-x | [XA] - PAWEL KARPINSKI ET AL, "Immunological landscape of consensus clusters in colorectal cancer", ONCOTARGET, (20171027), vol. 8, no. 62, doi:10.18632/oncotarget.22169, pages 105299 - 105311, XP055683316 [X] 11-15 * the whole document * * figure 3; table 1 * [A] 1-10 DOI: http://dx.doi.org/10.18632/oncotarget.22169 | [A] - RODRIGUEZ-SALAS NURIA ET AL, "Clinical relevance of colorectal cancer molecular subtypes", CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, (20170101), vol. 109, doi:10.1016/J.CRITREVONC.2016.11.007, ISSN 1040-8428, pages 9 - 19, XP029857764 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.critrevonc.2016.11.007 | [A] - FRATAMICO ROBERTO S ET AL, "Molecular Profiling in Colon Cancer: Where Are We Now?", CURRENT COLORECTAL CANCER REPORTS, SPRINGER US, BOSTON, vol. 13, no. 5, doi:10.1007/S11888-017-0385-2, ISSN 1556-3790, (20170826), pages 362 - 369, (20170826), XP036347711 [A] 1-15 * the whole document * * table 1 * DOI: http://dx.doi.org/10.1007/s11888-017-0385-2 | International search | [X]US2010190173 (COWENS WAYNE [US], et al) [X] 63-71 * ; abstract; paragraphs [0014], [0017], [0022], [0035], [0040], [0088], [0089], [0100], [0139], [0167], [0201] *; | [A]WO2017182656 (VIB VZW [BE], et al) [A] 1-7, 8/1-7, 9-48, 49/47-48, 50/49/47-48, 51/49/47-48, 52/51/49/47-48, 53/51/49/47-48, 54-62, 72-88, 91-92, 94-100 * ; page 3, lines 31-33; page 11, lines 31-33; page 23, lines 26-31; figure 2; table 2 *; | [A] - LINNEKAMP et al., "Consensus Molecular Subtypes Of Colorectal Cancer Are Recapitulated In In Vitro And In Vivo Models", Cell Death & Differentiation, (20180105), vol. 25, no. 3, doi:doi:10.1038/s41418-017-0011-5, pages 616 - 633, XP036444064 [A] 1-7, 8/1-7, 9-48, 49/47-48, 50/49/47-48, 51/49/47-48, 52/51/49/47-48, 53/51/49/47-48, 54-62, 72-88, 91-92, 94-100 * ; abstract; page 631, column 2, second paragraph. https://doi.org/10.1038/s41418-017-0011-5 * DOI: http://dx.doi.org/10.1038/s41418-017-0011-5 |